CKM 抗体 (full length)
Our Local Distributor
北京 101111
Quick Overview for CKM 抗体 (full length) (ABIN7878037)
抗原
See all CKM 抗体适用
宿主
克隆类型
标记
应用范围
质量等级
克隆位点
-
-
抗原表位
- full length
-
原理
- Creatine Kinase M Antibody / CKM (azide and preservative free)
-
纯化方法
- Protein G affinity chromatography
-
免疫原
- Recombinant full-length CKM protein was used as the immunogen for the Creatine Kinase M antibody.
-
亚型
- IgG2a, kappa
-
-
-
-
应用备注
- Optimal dilution of the Creatine Kinase M antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
储存液
- Azide free
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store the Creatine Kinase M antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- CKM (Creatine Kinase, Muscle (CKM))
-
别名
- Creatine Kinase M
-
背景
- T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31 % overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.
-
UniProt
- P06732
抗原
-